gdc

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members
Drugs for Breast Cancer
Breast Cancer
Here are the financial support services available to patients receiving treatment for Breast Cancer.
Blood-Based Biopsy Can Predict Breast Cancer Recurrence
Breast CancerWeb Exclusives
In patients with HR-positive breast cancer, a positive circulating tumor cells assay result was associated with nearly a 20-fold increased risk for recurrence of disease.
The Benefit of CDK4/6 Inhibitors Applies Equally to Older Women with Breast Cancer
Breast CancerWeb Exclusives
Older women with hormone receptor–positive, HER2-negative metastatic breast cancer who are treated with a CDK4/6 inhibitor may derive benefits similar to those seen in their younger counterparts.
Immunotherapy Continues to Gain Momentum in Breast Cancer
Breast CancerWeb Exclusives
Treatment with a regimen of pembrolizumab plus trastuzumab in patients with trastuzumab-resistant advanced HER2-positive breast cancer was well-tolerated and had clinical benefit in those whose tumors were positive for a biomarker for pembrolizumab.
Arm Morbidity Higher with Extensive Lymph Node Surgery in Younger Patients with Breast Cancer
Breast CancerWeb Exclusives
Patients under age 40 with breast cancer who underwent axillary lymph node dissection were more likely to experience arm swelling and decreased range of arm motion than patients who received less invasive sentinel lymph node biopsies.
Dose-Intense Chemotherapy Shown to Improve Outcomes in Patients with Breast Cancer
Breast CancerWeb Exclusives
According to the results of 2 recent analyses, dose-dense or dose-intense chemotherapy reduces the risk for breast cancer recurrence and improves survival compared with standard chemotherapy regimens.
A Novel Tissue Expander System Offers New Options in Breast Reconstruction
Breast CancerWeb Exclusives
For the first time in 40 years, patients who are considering reconstructive surgery after a mastectomy because of breast cancer have a new option for tissue expansion—the AeroForm Tissue Expander System.
Verzenio a New Targeted Therapy Approved for Metastatic Breast Cancer
Breast CancerFDA NewsNewsworthy
Read about Verzenio, which was approved by the FDA in 2017, in combination with fulvestrant, for treatment of women with HR-positive, HER2-positive, HER2-negative advanced, or metastatic breast cancer that progressed after endocrine therapy.
Neratinib First Long-Term Adjuvant Therapy for Early-Stage, HER2-Positive Breast Cancer
Breast CancerFDA NewsNewsworthy
On July 17, 2017, the FDA approved Nerlynx (neratinib; from Puma Biotechnology) for long-term adjuvant treatment of early-stage, HER2-positive breast cancer in patients who received previous therapy with Herceptin (trastuzumab).
The Aftershocks Kept Coming: What to Expect After Cancer Treatment
Breast CancerChemotherapySide-Effects Management
Breast cancer survivor Lisa D’Ottavio describes the side effects of treatment that she experienced, from chemo hair loss, neuropathy, and lymphedema, to radiation effects and more.
Page 2 of 5
Results 11 - 20 of 49

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country